Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens (Q35190921)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

14

Steven A Rosenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

6

Patrick Hwu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

7

Suzanne L Topalian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

12

Sharon A Mavroukakis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

Douglas J Schwartzentruber

5 November 2019

8

object named as

Douglas J Schwartzentruber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

9

Claudia A Seipp

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

10

Linda J Freezer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Giao Q Phan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Christopher E Touloukian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

James C Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Richard M Sherry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Kathleen E Morton

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Donald E White

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

published in

Journal of Immunotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

349-356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens

5 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

The central role of CD4(+) T cells in the antitumor immune response

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

A central role of CD40 ligand in the regulation of CD4+ T-cell responses

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

HLA associations in the antitumor response against malignant melanoma.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1679660

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12843797

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12843797

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The role of CD4+ T cell responses in antitumor immunity

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12843797

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/00002371-200307000-00007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12843797%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference